Corrigendum to 'A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report' [Eur J of Canc (2017) 206–225]

Autor: Astrid K. Gnekow, David A. Walker, Daniela Kandels, Susan Picton, null Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrom, Monika Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Irene Slavc, Giorgio Perilongo, Sue Picton, David Walker, Per Erik Sandstrom, Niels Clausen, Mikko Arola, Olafur Gisli Jonsson, Ofelia Cruz, Aurora Navajas, Anna Teijeiro, Chantal Kalifa, Marie-Anne Raquin, Joris Verlooy, Volkmar Hans, Wolfram Scheurlen, Johannes Hainfellner, James Ironside, Keith Robson, Kari Skullerud, David Scheie, null NN, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella-Branger, Arielle Lellouch-Toubiana, Daniela Prayer, Milena Calderone, Tim Jaspan, Soren Jacob Bakke, Eli Vazquez, Dominique Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, Jordi Giralt, Christian Carrie, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zerah, Bettina Wabbels, Maria Luisa Pinello, Alistair Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernaiz-Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Stromberg, Jose Ma Indiano, Chantal Rodary, Eric Bouffet, Didier Frappaz, Angela Emser, Suzanne Stephens, David Machin, Marie-Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto

Publikováno v: European Journal of Cancer

The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection.Within the European

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddc13a33f6fe385beac61c49f75440e
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144933

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

Autor: Angela Emser, Per-Henrik Groop, Mark E. Cooper, Hans-Juergen Woerle, Maximilian von Eynatten, Vlado Perkovic

Publikováno v: Diabetes Care

OBJECTIVE Preclinical data suggest that linagliptin, a dipeptidyl peptidase-4 inhibitor, may lower urinary albumin excretion. The ability of linagliptin to lower albuminuria on top of renin-angiotensin-aldosterone system (RAAS) inhibition in humans w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c124e53707cd212b3f9704adbe51a5
http://europepmc.org/articles/PMC3816860

Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: Report from the HIT-LGG 1996 trial

Autor: Angela Emser, Torsten Pietsch, Monika Warmuth-Metz, RD Kortmann, Astrid Gnekow, Ronald Straeter, Stephan von Hornstein, Niels Soerensen, Barbara Thieme, Norbert Graf

Publikováno v: Pediatric Blood & Cancer. 56:1046-1054

Background We describe demographic data of disseminated childhood low-grade glioma (DLGG) prospectively recruited in the HIT-LGG 1996 study and evaluate the impact of primary chemotherapy (CT) on the outcome of these tumors, which have previously onl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f092701ed934c618c7d01df6af957b7
https://doi.org/10.1002/pbc.23006

Relapse Pattern After Complete Resection and Early Progression After Incomplete Resection of Childhood Craniopharyngioma

Autor: Niels Sörensen, Fabian Pohl, R Kolb, Gabriele Calaminus, Angela Emser, Hermann L. Müller, Michael Flentje, Ursel Gebhardt, M. Warmuth-Metz

Publikováno v: Klinische Pädiatrie. 218:315-320

In HIT Endo data on therapy and prognosis of 306 patients with childhood craniopharyngioma (CP) were analyzed. The 5 years-overall survival rate was 94 +/- 4 % in irradiated patients and 93 +/- 5 % in non-irradiated patients. Aims of the prospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::516427ef321be3759b7b639322e11c3d
https://doi.org/10.1055/s-2006-942249

Functional capacity and body mass index in patients with sellar masses—cross-sectional study on 403 patients diagnosed during childhood and adolescence

Autor: R Kolb, N Etavard-Gorris, Niels Sörensen, Ursel Gebhardt, Angela Emser, Andreas Faldum, Hermann L. Müller

Publikováno v: Child's Nervous System. 21:539-545

We analyzed the impact of tumour localization and histology on functional capacity (FC) and body mass index (BMI) in children with sellar masses. FC was evaluated using the ability scale Fertigkeitenskala Munster–Heidelberg in 403 children and adol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231bd6b8d4b6e7bd932a10cffda27200
https://doi.org/10.1007/s00381-005-1166-9